Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate–Type Glutamate Receptor Function
Joshua T. Kantrowitz, Neal R. Swerdlow, Walter Dunn, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2018) Vol. 3, Iss. 7, pp. 581-590
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes, Richard Drake, Carol Paton, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 1, pp. 3-78
Open Access | Times Cited: 513
The Neuronal Basis of Predictive Coding Along the Auditory Pathway: From the Subcortical Roots to Cortical Deviance Detection
Guillermo V. Carbajal, Manuel S. Malmierca
Trends in Hearing (2018) Vol. 22
Open Access | Times Cited: 208
Dose-Dependent Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia: A Double-Blind, Placebo-Controlled, Randomized, Target Engagement Clinical Trial of the NMDA Glutamate Receptor Agonist d-serine
Pejman Sehatpour, Dan V. Iosifescu, Heloise M. De Baun, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 2, pp. 164-173
Open Access | Times Cited: 26
Finding the Right Dose: NMDA Receptor–Modulating Treatments for Cognitive and Plasticity Deficits in Schizophrenia and the Role of Pharmacodynamic Target Engagement
Pejman Sehatpour, Joshua T. Kantrowitz
Biological Psychiatry (2024) Vol. 97, Iss. 2, pp. 128-138
Closed Access | Times Cited: 7
Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double-blind, randomized, sham controlled, fronto-temporal, transcranial direct current stimulation (tDCS): A replication/extension study
Joshua T. Kantrowitz, Pejman Sehatpour, Michael Avissar, et al.
Brain stimulation (2019) Vol. 12, Iss. 4, pp. 981-991
Open Access | Times Cited: 50
Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patients
Joshua T. Kantrowitz, Daniel C. Javitt, Robert Freedman, et al.
Neuropsychopharmacology (2020) Vol. 45, Iss. 8, pp. 1339-1345
Open Access | Times Cited: 43
Targeting Serotonin 5-HT2A Receptors to Better Treat Schizophrenia: Rationale and Current Approaches
Joshua T. Kantrowitz
CNS Drugs (2020) Vol. 34, Iss. 9, pp. 947-959
Closed Access | Times Cited: 40
Psychosis spectrum illnesses as disorders of prefrontal critical period plasticity
Sophia Vinogradov, Matthew V. Chafee, Erik Lee, et al.
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 168-185
Open Access | Times Cited: 27
Recent Advances in the Early Intervention in Schizophrenia: Future Direction from Preclinical Findings
Kenji Hashimoto
Current Psychiatry Reports (2019) Vol. 21, Iss. 8
Closed Access | Times Cited: 35
Towards biologically constrained attractor models of schizophrenia
Heike Stein, João Barbosa, Albert Compte
Current Opinion in Neurobiology (2021) Vol. 70, pp. 171-181
Open Access | Times Cited: 25
D-Serine: A Cross Species Review of Safety
Amir Mohammad Meftah, Hiroshi Hasegawa, Joshua T. Kantrowitz
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 25
Acute subanesthetic ketamine-induced effects on the mismatch negativity and their relationship to early and sustained treatment response in major depressive disorder
Sara de la Salle, Jennifer L. Phillips, Pierre Blier, et al.
Journal of Psychopharmacology (2025)
Closed Access
NMDA Receptor Model of Antipsychotic Drug-Induced Hypofrontality
Marek Krzystanek, Artur Pałasz
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1442-1442
Open Access | Times Cited: 29
Why Cognitive Health Matters
Alice Medalia, Matthew Erlich
American Journal of Public Health (2016) Vol. 107, Iss. 1, pp. 45-47
Open Access | Times Cited: 26
A randomized controlled trial comparing a “bottom-up” and “top-down” approach to cognitive training in schizophrenia
Carol Jahshan, Sophia Vinogradov, Jonathan K. Wynn, et al.
Journal of Psychiatric Research (2018) Vol. 109, pp. 118-125
Open Access | Times Cited: 26
The Potential Role of Lumateperone—Something Borrowed? Something New?
Joshua T. Kantrowitz
JAMA Psychiatry (2020) Vol. 77, Iss. 4, pp. 343-343
Closed Access | Times Cited: 21
Computational Synaptic Modeling of Pitch and Duration Mismatch Negativity in First-Episode Psychosis Reveals Selective Dysfunction of the N-Methyl-D-Aspartate Receptor
Fran López‐Caballero, Ryszard Auksztulewicz, Zachary L Howard, et al.
Clinical EEG and Neuroscience (2024)
Closed Access | Times Cited: 2
Using EEG-Guided Basket and Umbrella Trials in Psychiatry: A Precision Medicine Approach for Cognitive Impairment in Schizophrenia
Yash B. Joshi, Gregory A. Light
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 18
Trace Amine-Associated Receptor 1 as a Target for the Development of New Antipsychotics: Current Status of Research and Future Directions
Joshua T. Kantrowitz
CNS Drugs (2021) Vol. 35, Iss. 11, pp. 1153-1161
Closed Access | Times Cited: 13
The Less Things Change, the More They Remain the Same: Impaired Neural Plasticity as a Critical Target for Drug Development in Neuropsychiatry
Joshua T. Kantrowitz, Daniel C. Javitt
Advances in neurobiology (2024), pp. 801-828
Closed Access | Times Cited: 1
Grant Report on d-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †.
Natalie de la Garrigue, Juliana Glasser, Pejman Sehatpour, et al.
PubMed (2020) Vol. 5, Iss. 4
Closed Access | Times Cited: 6
Neuroplasticity and Cognitive Training in Schizophrenia
Sujita Kumar Kar, Amit Singh
Current Behavioral Neuroscience Reports (2019) Vol. 6, Iss. 3, pp. 113-118
Closed Access | Times Cited: 3
Towards biologically constrained attractor models of schizophrenia
Heike Stein, João Barbosa, Albert Compte
(2021)
Open Access | Times Cited: 2
Synchronized Auditory Gamma Response to Frontal Transcranial Direct Current Stimulation (tDCS) and its Inter-Individual Variation in Healthy Humans
Sara de la Salle, Urusa Shah, Molly Hyde, et al.
Clinical EEG and Neuroscience (2022) Vol. 53, Iss. 6, pp. 472-483
Closed Access | Times Cited: 1
Augmentation of learning in schizophrenia by D-serine is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study
Viraj Govani, Adithya Shastry, Daniel Iosifescu, et al.
Research Square (Research Square) (2023)
Open Access
Page 1 - Next Page

Scroll to top